If this sounds familiar, its often connected to deeper metabolic factors
The GLP-1/Notch signaling within the distal niche maintains the mitotic cell fate of germline SPCs (Hansen and Schedl, 2006
instead, they should only progress to an increased dose when tolerance is demonstrated
And some of the most meaningful benefits of GLP-1 therapy may be happening beneath the surface, inside the arteries, the heart, and the metabolic systems that quietly shape our long-term cardiovascular outcomes
These results indicate that the SNR exhibited the greatest contribution to the prediction of biochemical factors, followed by the LDA-texture index and CFDS slope
We can often adjust the dose, stay at a certain dose longer, or even add nausea medication when appropriate